Behavioral Activation Therapy for Depression After Respiratory Failure
(BEHAB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
More and more people are surviving after receiving life support for respiratory failure in the intensive care unit, but these patients often experience problems with depression and physical functioning that lead to reduced quality of life. There is a lack of treatment for these patients, with past research suggesting that treatment may be more successful if mental and physical health are addressed at the same time. This research evaluates whether a therapy delivered via telephone and home visits, combining treatment for depression and physical rehabilitation, is feasible and might help patients recover.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
Is Behavioral Activation Therapy safe for humans?
How is Behavioral Activation Therapy unique for treating depression after respiratory failure?
Behavioral Activation Therapy is unique because it focuses on increasing engagement in enjoyable activities to boost positive reinforcement, which can be particularly beneficial for patients recovering from respiratory failure who may struggle with depression. Unlike other therapies, it can be delivered by practitioners with less psychological training, making it accessible and suitable for various settings.16789
Who Is on the Research Team?
Ann M Parker, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for adults over 18 who were living at home before ICU admission, experienced acute respiratory failure requiring intensive care for more than 24 hours, and have mild depressive symptoms. Excluded are those with long ICU stays, substance abuse or psychosis, severe prior disability, non-English speakers, homelessness or living far from the study site.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Behavioral Activation and physical rehabilitation via telephone and 2 home visits over 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Behavioral Activation - Rehabilitation
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator